When the contract runs out on the FDA&#8217;s pilot version of its Sentinel postmarket surveillance program in 2014, the agency plans a three-pronged expansion to include a new data-only portal drugmakers can use for research.<p>Source: <a href="http://www.fdanews.com/newsletter/article?articleId=153061&issueId=16538">http://www.fdanews.com/newsletter/article?articleId=153061&issueId=16538</a></p><p><a href="http://www.discountmedicaldevices.com/medical-supply-and-equipment/">FDAnews Device Daily Bulletin</a> <a href="http://www.diigo.com/user/gusspeck1230">QMN Weekly Bulletin</a> <a href="http://en.netlog.com/thomasjacobs49/blog/blogid=10634984">FDAnews Drug Daily Bulletin</a> <a href="http://www.migente.com/your_page/blog/view_posting.html?pid=3076504&profile_id=7306675&profile_name=curtpagh614&user_id=7306675&username=curtpagh614">Electronic Medical Records</a> <a href="http://www.migente.com/your_page/blog/view_posting.html?pid=3076703&profile_id=7306424&profile_name=gusspeck1230&user_id=7306424&username=gusspeck1230">Healthcare Reform</a> </p>

Leave a Reply